Lixte Biotechnology Holdings financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

NASDAQ:LIXT · Nasdaq · Healthcare

$7.21+0.00%

2026-07-07 close

Lixte Biotechnology Holdings's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$4M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy